Investment Q&A

Q: Under the "lottery ticket" portion of my portfolio I own SVA, they announced a deal with EVO. RBC has no information on EVO, what can you tell me about EVO, thoughts on the deal?

Q: I have dabbled in a few mid to small cap Canadian bio companies over the years. I never have the stomach to hold on for the long term in general due to high volatility but I like the sector. I'm currently sitting on Sernova (SVA) for now at least. How Do you like them? Do you have any other recommendations in this sector?

Q: Sernvova Corp. is spiking upward. Any news and your opinion on the company and their technology. Thank you for your expert opinion.

Q: I am under the impression a company must release any material news asap? If so, is it a fair presumption a release like this means the news isnt material? "Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare Conference"

Q: Can you provide your brief assessment of these stocks whether they are good investments over 5 years? Thanks

Q: Regarding todays nr, is it safe to assume the observations from the clinical trial are in a positive light? I have a small position and am considering adding - since the casino is closed. London, Ontario-TheNewswire -June 1, 2021 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF)(FSE/XETRA:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that lead principal investigator Dr. Piotr Witkowski and the Clinical Trial Investigator Team for its US Phase I/II Type 1 Diabetes clinical trial will present data and observations from the ongoing study in a presentation at the upcoming American Transplant Congress (ATC) Virtual Connect to be held June 4 - 9, 2021.

Q: Recognizing that these two companies are in vastly different industries, which one would you choose for a 3/5 year hold and why.
Thanks
David

Q: This small cap is way up. Do you think it has legs?

Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks

Q: Here is a good presentation on Sernova from the president. It touches on market size. Talks about potentials revenue streams and their thoughts on market sizing. A fun number was "untapped $2B market". I'm in since 0.42.

https://journey.ct.events/view/3a577711-041b-48a3-8b1c-0d47129bb30c

The two big ones:
- Type 1 diabetes
- Hyperthyroidism and Hashimoto's

Q: Given todays news how does one go about valuing the company. The news seems very positive.

Q: Why do you think this small cap has bumped up so much lately?

Q: You have commented on Sernova in response to several questions since 2013. DoEs its movement since the first of December, 2020 indicate som form of “critical mass” has been achieved?

Q: Can I please have your opinion & outlook for Sernova Corp. Thanks to all 5i staff. Merry Christmas & Happy New Year.
Richard

Q: Hi 5i: Can you give me an update on Sernova?

Q: I noticed that it has been nearly 4 years since you last commented on this company so I would appreciate it if you could provide an update.

Keep up the great work.

Q: Hi Peter and team, Servova (SVA) jumped 14% on Friday. Can you translate the warrant and options news? It looks like an investor thinks .20 will be a bargain price sometime in the next 2 years?? Could you provide some insight please? Thank you.